Equities

Vitalhub Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Vitalhub Corp

Actions
  • Price (EUR)5.00
  • Today's Change-0.10 / -1.96%
  • Shares traded110.00
  • 1 Year change-34.64%
  • Beta0.8097
Data delayed at least 15 minutes, as of Feb 10 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Vitalhub Corp. is a software company dedicated to empowering health and human services providers globally. The Company’s product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,000 clients across the United Kingdom, Canada, and other geographies. Its portfolio of patient flow, operational visibility and patient journey optimization solutions are designed for complex hospital and integrated health environments. It offers electronic health record, case management, care coordination and optimization solutions to inpatient/outpatient care providers, long-term care, and community and social services-focused organizations. Its EHR solutions are easy to use, workflow adaptable and customizable. Its solutions include Alamac, Beautiful Information, Hicom, Intouch with Health, MCAP, Oculys, and SHREWD. It also offers a series of integrated software modules providing referral management, and surgical wait list management.

  • Revenue in CAD (TTM)98.17m
  • Net income in CAD2.83m
  • Incorporated2015
  • Employees500.00
  • Location
    Vitalhub Corp480 University Avenue, Suite 1001TORONTO M5G 1V2CanadaCAN
  • Phone+1 (647) 965-4721
  • Fax+1 (647) 965-4721
  • Websitehttps://vitalhub.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
VHI:TOR since
announced
Transaction
value
Novari Health IncDeal completed07 Jul 202507 Jul 2025Deal completed-25.65%35.79m
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.